Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1A/1B Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

NCT06792734 is registered in ClinicalTrials.gov with Bantam Pharmaceuticals as lead sponsor.

NCT NCT06792734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06792734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1A/1B Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
Lead sponsor
Bantam Pharmaceuticals
Phase
Phase 1
Overall status
Recruiting
Start date
February 14, 2025
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, b-cell